GlycoMimetics, Inc. (NASDAQ: GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases,…
Calling all pediatric cardiovascular devices $100K competition now accepting proposals We are now accepting proposals for our annual pediatric medical…